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Summary
Background. — Optimal treatment of type B dissections is open to debate. The use of
endoprostheses is an option that requires evaluation.
Aim. — To report our experience with endoprostheses in type B aortic dissections.
Methods. — We report our short- and medium-term results with covered prostheses for the
treatment of acute (n=7) and chronic (n=28) type B aortic dissections. The criteria used to
indicate treatment were the same as those usually used for surgery: acute complications or
dilated aneurysm. Cover of the main intimal tear was obtained in all cases with an improvement
in symptoms in patients with acute dissections.
Results. — Early mortality was 14.3% (five patients), linked in three cases to the occurrence of
a retrograde dissection of the ascending aorta. No neurological complications were observed.
Four patients required an additional endovascular and/or surgical procedure.
On early control scans, complete thrombosis of the false lumen at the thoracic level was observed in
40% of cases, partial thrombosis in 42.8% and an absence of thrombosis in 11.4%. After a mean follow-
up of 20.8 months, one patient died of a pneumopathy. No secondary aneurysm expansion was noted
at the thoracic stage whereas three patients presented with dilation of the abdominal aorta.
Conclusion. — The results of treatment of type B dissections with covered endoprostheses are
encouraging. However, the morbimortality associated with treatment and the uncertainty of
long-term results do not allow the use of this therapeutic option outside the criteria usually
recognized to indicate surgery.
© 2008 Published by Elsevier Masson SAS.
Résumé
Justification. — Le traitement optimal des dissections de type B dissections est discuté.
L’utilisation des endoprothèses est une technique d’apparition relativement récente qui doit
être validée.
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Objectifs. — Rapporter l’expérience de notre centre dans le traitement par endoprothèses des
dissections de type B.
Méthodes. — Nous rapportons les résultats à court et moyen terme du traitement par
endoprothèse couverte des dissections aortiques de type B aiguës (n = 7) ou chroniques (n = 28).
Les critères retenus pour poser l’indication de traitement étaient ceux habituellement utilisés
pour la chirurgie : complication aiguë ou dilatation anévrismale.
Résultats. — La couverture de la porte d’entrée principale a été obtenue dans tous les cas avec
un amendement des symptômes dans le cas des dissections aiguës. La mortalité précoce a été
de 14,3 % (5 patients), liée dans 3 cas à la survenue d’une dissection rétrograde de l’aorte
ascendante. Aucune complication neurologique n’est survenue. Quatre patients ont nécessité
une procédure endovasculaire et/ou chirurgicale associée.
Sur le scanner de contrôle précoce, on notait une thrombose complète du faux chenal à l’étage
thoracique dans 40 % des cas, une thrombose partielle dans 42,8 % et une absence de
thrombose dans 11,4 %. 
Après un suivi moyen de 20,8 mois, un patient est décédé d’une pneumopathie. Aucune
expansion anévrismale secondaire n’a été notée à l’étage thoracique tandis que 3 patients ont
présenté une dilatation de l’aorte abdominale.
Conclusion. — Les résultats du traitement par endoprothèse couverte des dissections de type B
sont encourageants. Toutefois, la morbi-mortalité associée au traitement et l’incertitude
quant aux résultats à long terme ne permettent pas actuellement d’utiliser cette option
thérapeutique en dehors des critères habituellement reconnus d’indication chirurgicale.
© 2008 Published by Elsevier Masson SAS.
Introduction
Type B dissections involve only the descending aorta. In
acute cases, the reference treatment for these dissections
is medical and is associated with prolonged follow-up: most
clinicians will not consider surgical treatment unless there
is a complication (visceral malperfusion, refractory pain,
etc.) [1-4]. In chronic type B dissections, however, surgical
treatment is considered when there is an expanding dilated
aneurysm. The surgical approach used in this aortic patho-
logy is associated with a high morbimortality [5]. Implanta-
tion of endoprostheses has been proposed as alternative
therapy for patients at high surgical risk. However, endo-
vascular treatment of type B dissections is not without
complications [6], although few data are currently available
in the literature. We report our short- and medium-term
experience of endovascular treatment of type B dissections,
highlighting the limitations and complications of this new
technique.
Patients and methods
This retrospective study investigated our experience with
endovascular treatment of acute (n = 7; 20.0%) and chronic
(n = 28; 80%) type B dissections over a 6-year period. The
study population comprised 26 males (74.2%) and nine fema-
les (25.8%), with a mean age of 63.4 ± 8.6 years (41-83 years).
In all cases, the characteristics of the dissection were analyzed
using a thoraco-abdominal angio computed tomography (CT)
scan with contiguous slices of 1mm.
By definition, any dissection treated 14 days or later after
the appearance of symptoms was considered to be chronic.
The indications for treatment were identical to those usually
used for surgery. In acute cases, these consisted of either
the persistence of pain refractory to analgesics (n=1), or the
existence of a rupture revealed by the presence of a hemo-
thorax (n = 1), or visceral malperfusion (n = 5). In theses
cases, the clinical diagnosis of malperfusion (ischemia of a
lower limb (n = 2), abdominal pain (n = 3), oligo-anuria
(n = 2)) was confirmed using an angioscanner. It should be
noted that patient had a gastro-intestinal claudication and
that several patients presented with several complications.
As far as chronic dissections are concerned, the indication
for endovascular treatment was determined by the diame-
ter of the aneurysm (> 60mm) and/or it evolutive charac-
ter. In all cases, the medical findings were discussed jointly by
a vascular radiologist and a cardiovascular surgeon pre-sur-
gery, to decide on procedures and follow-up.
Procedures
All procedures except for one were carried out in a surgical
unit equipped with a mobile C-arm and a radiotransparent
operating table with carbon fibers.
Implantation of the endoprosthesis was carried out under
general (n = 31; 88.5%), local (n = 3; 8.5%), or loco-regional
(n = 1; 2.8%) anesthesia. In all cases except one, a surgical
approach via the common femoral artery (or the external
iliac artery if there was insufficient diameter) was used to
introduce the prosthesis.
The prosthesis was released in the true channel for all
patients except one (deliberately placed in the false chan-
nel). Antibiotic prophylaxis (second generation cephalosporin)
and one dose of non-fractionated heparin (100UI/kg) were
administered before implantation in all cases.
The endovascular sequence of events consisted of the
systematic introduction of a standard metallic guidewire,
followed by a pigtail catheter allowing the introduction of a
rigid guidewire, which permitted positioning of the cathe-
ter carrying the endoprosthesis. A pigtail catheter was also
introduced percutaneously via the left humeral artery to
locate the left subclavian artery and enable aortography to
be carried out. In all cases, the objective of the endo-
prosthesis was to cover the main thoracic intimal tear to
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decrease the pressure in the false channel and facilitate its
thrombosis. Anatomically, the only criterion necessary was
the existence of a non-dilated proximal neck of the aorta,
at least 1.5 cm long; this was measured from the left primi-
tive carotid artery. When the tear was close to the left sub-
clavian artery, the latter was covered after a preoperative
angioscan had ensured the functional character of the polygon
of Willis. The artery of Adamkiewicz was not investigated.
Only autoexpandable stents were used: Talent® (Medtro-
nic Inc, Sunrise, FL, USA) in 15 patients (42.8%), TAG® (Gore
Tex Inc, Sunnyvale, CA, USA) in 14 (40%), Excluder® (Gore Tex
Inc, Sunnyvale, CA, USA) in five (14.4%) and Zenith® (Cook
Inc, Bloomington, IN, USA) in one patient (2.8%). The choice
of endoprosthesis depended on their availability, the ana-
tomy of the patient and of the lesion. A discrete oversizing
of 10% compared to the diameter of the aorta, measured
preoperatively on CT-scan images, was used in all cases.
Eight patients received more than one endoprosthesis
(maximum of four) and a total of 46 endoprostheses were
implanted. The diameters of the implanted endoprostheses
varied from 30 to 42 mm (mean 33.5 mm). After implanta-
tion, patients were observed in intensive care for a minimum
period of 2 hours and then went onto the general hospital
ward where they stayed for at least another 24 hours.
Follow-up
All patients (except for two who died early) underwent CT-
scan with injection of contrast medium before leaving hos-
pital, on the first or second day post-surgery. Patients were
seen again in the clinic 1 week after leaving hospital to
check on healing of the femoral access. Scannographic follow-
up was then scheduled for the following times post-surgery:
6, 12, 18 and 24 months. Mean follow-up was 20.8 months;
median follow-up was 12 months (1-80 months).
Results
Short-term results (at 30 days)
The dissection tear was successfully covered in all endo-
vascular procedures (100%). No surgical conversion was
carried out. For acute dissections, improvement of symptoms
was obtained in all cases.
For all our patients, complete thrombosis of the false
channel at the thoracic level was obtained in 14 patients
(40.0%), partial thrombosis in 15 (42.8%) and an absence of
thrombosis in only four patients (11.4%). Two patients who
died early did not undergo a control scan. The details as a
function of the type of dissection are shown in table 1.
No cerebral or medullar neurological accidents were
observed. The left subclavian artery was deliberately occlu-
ded in 10 patients (28.6%), without immediate ischemic
complications (one case of claudication of an upper limb
occurred later).
Early mortality was 14.3% (five patients). Three of these
patients suffered a ruptured retrograde dissection of the
ascending aorta. One patient had a ruptured aorta 5 hours
after placement of the endoprosthesis and died on day 2
due to multiorgan failure, despite complete replacement
of the ascending aorta as an emergency procedure. The
second had a ruptured aorta on day 10 and died before sur-
gery could be performed. The third underwent surgery for
type I retrograde dissection on day 4 with replacement of
the ascending aorta. Two days later he suffered a major
hemorrhage (rupture of the anastomotic suture on the
endoprosthesis stent) and died soon after in intensive care.
One patient died suddenly on day 22 post-implantation,
while he was in intensive care for multiorgan failure. This
patient presented with an acute dissection associated with
mesenteric ischemia. Although no autopsy was performed,
the most likely cause of death was rupture of the descen-
ding thoracic aorta. The final patient died of pneumonia,
several days after leaving hospital.
Four patients required an associated endovascular and/
or surgical procedure: carotid- subclavian by-pass (1), caro-
tid-carotid by-pass (1), endoprothesis of the infra--renal
abdominal aorta (1), stent of the superior mesenteric
artery and of a renal artery (1).
The incidence of early mortality was 27.8% (table 2).
Medium-term results
At the mean follow-up time of 20.8 months, 29 patients
were alive, without any lost to follow-up. One patient
(3.3%) died during the follow-up period from septic shock
on top of probable inhalation pneumopathy during the
second month post-surgery (patient treated with immuno-
suppressants).
No patient presented with an aneurysm expansion of the
thoracic aorta, whereas an aneurysm expansion of the
abdominal aorta was found in three patients (15.8%). Five
patients required a supplementary endovascular and/or
surgical procedure during the follow-up period (table 3).
Finally, no stent rupture and no migration of the endo-
prosthesis were observed in our series.
Discussion
Our study reports the short- and medium-term results of endo-
vascular treatment of acute and chronic type B dissections.
We observed a high early mortality (14.3% at day 30),
although it was lower than that reported recently by Böc-
kler in a comparable study (19% of 29 implanted patients)
[6]. Dake also reported a series of 19 endovascular treatments
for complicated acute type B dissections with an early
Table 1 Extent of thrombosis of the false lumen
according to type of aortic dissection.
Thrombosis of the false lumen
Dissection Complete Partial Absent
Acute (n=7) 2 3 2
Chronic* 
(n=28)
12 12 2
*Two patients died before an early post-operative control scan 
could be performed.
Partial thrombosis: only at the level of the endoprosthesis
Complete thrombosis: the entire aorta, even below the endo-
prothesis
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mortality of 16% [7]. In our series, three of the five deaths
were linked to retrograde dissection of the ascending aorta
and a fourth to a probable rupture. These complications are
certainly linked to the creation of a new tear either at the
time of the procedure or more probably due to direct con-
tact between the endoprosthesis and the fragile aorta.
These new intimal tears lead to the formation of a new dis-
section or an aneurysm in 10-20% of treated patients. In our
center, we have tried to decrease the risk by using more
flexible prostheses, by limiting oversizing, and by abo-
lishing implementation of the prosthesis by inflating a bal-
loon. Nevertheless, the last case of retrograde dissection
occurred despite these precautions.
Other complications were rare and were not associated
with an increase in the mortality rate in ours series. These
consist of peripheral vascular problems, accessible to surgi-
cal or endovascular treatment. The minimal invasive cha-
racter of the procedure allows us to limit the incidence of
potentially fatal post-operative complications observed
after conventional surgery. Another advantage of endovas-
cular treatment appears to be the extremely low incidence
of medullary ischemic complications despite the long
length of cover, sometimes over the entire descending tho-
racic aorta. In our series, no spinal cord injury were obser-
ved. In the retrospective register for the Talent endopros-
thesis, Fattori et al. reported four cases of such a
complication among 180 patients (2%), of which half consis-
ted of regressive paraparesis [8]. The only risk factor found
was a length of cover greater than 20 cm. Other studies
have reported a similar rate of spinal cord injury. Several
explanations can be put forward to explain the low inci-
dence of paraplegia post endovascular treatment: absence
of aortic clamping, effective and adequate collaterality,
decreased blood loss and correlated hypotension, deploy-
ment at a distance from the Adamkiewicz artery and over a
short portion of the aorta corresponding to the intimal tear.
Anatomically, a minimum distance of 1.5 to 2 cm is clas-
sically accepted as the optimum proximal neck to avoid
type I endoleaks. To obtain sufficient proximal anchorage,
it was necessary to cover the left subclavian artery in 10
patients (28.6%). As recommended by several authors, the
permeability of the polygon of Willis was confirmed whene-
ver possible by pre-implantation scans [9]. A case of claudi-
cation of a left upper limb was observed more than 2 years
after endovascular management, requiring subclavian-caro-
tid transposition. Two patients benefited per-implantation
from surgical revascularization of the supra-aortic trunk. In
these two cases, post-operative course was uncomplicated.
Our results are similar to those reported by Palma from a
large series of 70 type B aortic dissections treated by the
endovascular route: 14 patients (20%) had the left subcla-
vian covered by the stent, one had a subclavian-carotid by-
pass 8 months post-implantation [10]. However, in the
series of Fattori, covering the subclavian artery was a risk
factor for a cerebral vascular accident [8].
An incidence of reintervention or death of up to 40% was
found during long-term follow-up of patients who under-
went type B aortic dissection by conventional open surgery.
This was due to aortic pathology in the 7 years following the
initial intervention [11]. Obtaining thrombosis of the false
lumen and stabilization of the true lumen are the two
essential therapeutic objectives in order to prevent the
development of a dilated aortic aneurysm. When this
objective is achieved, it is possible to obtain complete
retraction of the false channel (figure 1). In our series,
complete thrombosis of the false lumen at the thoracic
level was obtained in 14 patients (40.0%), partial thrombo-
sis in 15 (42.8%) and the absence of thrombosis in four
patients only (11.4%). It should be noted that for two
patients who died early, a control scan was not performed.
In a recent comparable study carried out on 29 type B dis-
sections by the endovascular method, the observed rate of
total or partial thrombosis of the false lumen was 44% [6].
Dialetto reported a series of type B dissections comparing
Table 2 Table 2. Associated morbidity.
Type (n) Treatment
Vascular lesion Iliac dissection (1)
Iliac rupture (1)
Lower limb ischemia (1)
Open surgical repair
Aseptic fever 4 Corticotherapy for 6 months 
in one patient
Renal subcapsular hematoma 1 Surveillance
Septic shock on top of renal necrosis 
(linked to the dissection)
1 Medical treatment
Endoleak - type I From the left subclavian artery (1) Percutaneous occlusion 
of the left subclavian artery
Table 3 Additional procedures during follow-up.
Type Delay
Abdominal aortic fenestration + renal 
arterial stent for persistent hypertension
3 months
Treatment of endoleak type I by endo-
prosthesis
6 months
Completion of occulsion of left subclavian 
artery
7 months
Subclavian-carotid transposition 
for claudication of upper limb <??>
27 months
Surgery for abdominal aorta aneurysm 52 months
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28 patients treated medically and 28 treated by the endo-
vascular method. Thrombosis of the false lumen was obser-
ved in 10.7% (3/28) of patients treated medically versus
72% (18/25) of surviving patients treated by the endovascu-
lar method [12].
It is important to note the efficacy of endovascular treat-
ment for acute complications, particularly ischemic, asso-
ciated with acute dissections. Only one of seven patients
who presented with an acute complication died (14%). In a
recent study by Sakakura et al. reporting an incidence of
acute complications of 7% in a retrospective study of 200
type B dissections, these complications were associated
with a mortality of 50% [13]. In the international register of
acute dissections, 17% of 472 patients hospitalized for
acute type B dissections underwent surgery for acute com-
plications with a mortality rate of 29% [14]. In the case of
ischemic complications related to a dynamic occlusion,
some authors propose carrying out fenestration. In our
decisional algorithm, this therapeutic approach remains
second choice, if it is not possible to treat the intimal tear
with an endoprosthesis [15].
Concerning chronic dissections, treatment is usually indi-
cated when the diameter of the aorta exceeds 60 to 65 mm.
It is difficult to compare the results of endovascular treat-
ment with surgical treatment for two reasons. First, there
have been few surgical studies and those that have been
performed have mixed different types of aneurysms in
terms of their etiology and size [16]. Secondly, irrespective
of the size of the aneurysm endovascular therapy only
treats the thoracic component, but there are occasionally
repercussions at the infra-diaphragmatic level. In the large
surgical surveys, the risk of surgery and the risk of paraple-
gia vary between 2 and 10% and 8 and 16%, respectively, as
a function of the extent of surgery. The incidence of para-
plegia can be decreased by carrying out systematic drainage
by LCR during the operation.
Treatment failure can be due to the presence of an endo-
leak. There are four types of endoleak: 1) Type I: leak at
the ends of the prosthesis due to a fault with attachment;
2) Type II: retrograde leak originating from a collateral
branch; 3) Type III: tear in the cover of the prosthesis or
defect in the overlap between two prostheses; 4) Type IV:
porosity of the prosthesis cover.
Type III and type IV leaks are rare, and type II endoleaks
are more frequent at the abdominal level. In our series, one
patient presented a type I leak from the left subclavian
artery. This was treated by embolization. In the case of dis-
sections, the notion of endoleaks has not been determined.
Indeed, if we defined any persistence of opacification of
the false channel as an endoleak, then this was noted in 53%
of the patients in our series. However, in most cases this
opacification is related to intimal tears situated in the non-
treated aorta and below the endoprosthesis. This is why it
appeared more logical to us to evaluate our results in terms
of thrombosis of the false channel and evolution of the dia-
meter of the aneurysm.
Post-implantation fever is an unfortunate phenomenon
and was observed in four of our patients, all of whom were
treated for chronic dissection. Fever can be prolonged,
sometimes for several weeks, and exceptionally several
months. Attributed to inflammatory phenomena and degra-
dation of the thrombus in the false lumen, it does not usually
require the use of antibiotics because of its non-infectious
etiology. Treatment with antipyretics (paracetamol) for
several days, occasionally combined with non-steroidal
anti-inflammatory drugs, is usually sufficient [17]. Rarely,
this fever may be prolonged requiring (one case in our study)
protracted treatment with oral corticosteroids. Taking all
this into account, infection of the prosthesis should always
be considered if fever occurs after implantation of a foreign
body and the necessary examinations should be carried out
on a case by case basis, taking clinical factors into account.
Conclusion
Endovascular treatment of type B aortic dissections has a
place in the therapeutic arsenal of the cardiovascular sur-
geon. Our short- and medium-term results with this technique
lead us to propose this therapeutic approach as an alterna-
tive to conventional open surgery taking into account the
Figure 1. Control scans of endoprosthesis treatment of a type B dissection. 
A: Scan immediately after treatment. B: Scan at 1 year demonstrating complete retraction of the false lumen.
A
B
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high risk associated with the latter technique. However,
complications do occur with endovascular treatment and
the absence of long-term data do not enable us to recom-
mend the systematic implantation of a vascular endo-
prosthesis for an asymptomatic and/or uncomplicated type
B aortic dissection.
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